Alto Neuroscience ANRO Total Equity
Total Equity at other companies
Other financials
Where this comes from
Reported directly by Alto Neuroscience in its filing.
Tagged under the XBRL concept us-gaap:StockholdersEquity.
The official record: Alto Neuroscience’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Alto Neuroscience's total equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Alto Neuroscience's total equity?
- Alto Neuroscience (ANRO) reported total equity of $243.37M in Q1 2026.
- How has Alto Neuroscience's total equity changed year-over-year?
- Alto Neuroscience's total equity increased by 75.0% year-over-year, from $139.1M to $243.37M.
- What is the long-term trend for Alto Neuroscience's total equity?
- Over 3 years (2022 to 2025), Alto Neuroscience's total equity has grown at a 57.9% compound annual growth rate (CAGR), from -$38.41M to $151.14M.
- What does total equity mean?
- Net assets attributable to shareholders — total assets minus total liabilities. Represents the book value of shareholders' ownership claim.